Aspire Biopharma Holdings Inc. (NASDAQ: ASBP) announced that its board of directors has authorized the repurchase of up to $5 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE